Skip to main content

Marshall Wace, LLP

SEC CIK
0001318757
Latest filing
Aug 13, 2026

XENE holding history

Xenon Pharmaceuticals Inc. in every 13F filed by Marshall Wace, LLP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

XENE overviewAll 13F holders of XENEFull Q2 2026 holdings

Shares (Q2 2026)
689,342
Value
$41.6M
% of portfolio
<0.1%
Quarters held
20
Since Q2 2021
Holdings of XENE by Marshall Wace, LLP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026689,342$41.6M<0.1%+689,342NewHolders
Q1 20260$00.0%−162,551−100.0%Sold outHolders
Q4 2025162,551$7.29M<0.1%−449,431−73.4%ReducedHolders
Q3 2025611,982$24.6M<0.1%−408,272−40.0%ReducedHolders
Q2 20251,020,254$31.9M<0.1%+262,109+34.6%AddedHolders
Q1 2025758,145$25.4M<0.1%−141,573−15.7%ReducedHolders
Q4 2024899,718$35.3M<0.1%−295,762−24.7%ReducedHolders
Q3 20241,195,480$47.1M0.1%−189,194−13.7%ReducedHolders
Q2 20241,384,674$54.0M0.1%−65,668−4.5%ReducedHolders
Q1 20241,450,342$62.4M0.1%−78,306−5.1%ReducedHolders
Q4 20231,528,648$70.4M0.1%−625,746−29.0%ReducedHolders
Q3 20232,154,394$73.6M0.2%−166,025−7.2%ReducedHolders
Q2 20232,320,419$89.3M0.2%−1670.0%ReducedHolders
Q1 20232,320,586$83.1M0.2%−45,592−1.9%ReducedHolders
Q4 20222,366,178$93.3M0.2%−444,917−15.8%ReducedHolders
Q3 20222,811,095$101.5M0.3%+820,723+41.2%AddedHolders
Q2 20221,990,372$60.5M0.1%+456,314+29.7%AddedHolders
Q1 20221,534,058$46.9M0.1%+313,101+25.6%AddedHolders
Q4 20211,220,957$38.1M0.1%+1,191,154+3,996.8%AddedHolders
Q3 202129,803$456.0K<0.1%+19,350+185.1%AddedHolders
Q2 202110,453$195.0K<0.1%+10,453NewHolders